In patients with stage IV gastric cancer, REG Iα is a potent predictive marker of resistance to chemotherapeutic drugs [82], and furthermore, serum REG IV protein is a novel predictive marker of resistance to 5-FU-based chemotherapy in patients with gastric cancer [83]. The gene discussed is REG4; the disease is gastric cancer.